The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent

Atherosclerosis

Volumn 241, Issue 1, 2015, Pages 111-120

  Guo, June ^a   Breen, Danna M ^a   Pereira, Troy J ^b   Dalvi, Prasad S ^a,f   Zhang, Hangjun ^a   Mori, Yusaku ^a,c   Ghanim, Husam ^d   Tumiati, Laura ^e   Fantus, I George ^a   Bendeck, Michelle P ^a   Dandona, Paresh ^d   Rao, Vivek ^e   Dolinsky, Vernon W ^b   Heximer, Scott P ^a   Giacca, Adria ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c SHOWA UNIVERSITY   (Japan)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Angioplasty; Endothelial nitric oxide synthase; Insulin; Neointima; Re endothelialization

Indexed keywords

BOVINE INSULIN; CD31 ANTIGEN; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; GELATINASE A; GELATINASE B; GLUCOSE; I KAPPA B BETA; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; STRESS ACTIVATED PROTEIN KINASE 1; THROMBOPLASTIN; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASODILATOR STIMULATED PHOSPHOPROTEIN; DRUG IMPLANT; ENZYME INHIBITOR; NOS3 PROTEIN, MOUSE; NOS3 PROTEIN, RAT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA INJURY; ARTERY INJURY; ARTICLE; BALLOON CATHETER; CAROTID ARTERY INJURY; CELL MIGRATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMORAL ARTERY; FEMORAL ARTERY INJURY; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN IMPLANT; LEFT COMMON CAROTID ARTERY; MALE; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; TRIACYLGLYCEROL BLOOD LEVEL; VASOCONSTRICTION; VASODILATATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CAROTID ARTERY INJURIES; CELL MOTION; COMMON CAROTID ARTERY; DEFICIENCY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; DRUG IMPLANT; ENZYMOLOGY; EPITHELIZATION; GENETICS; INJURIES; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TIME FACTOR; VASCULAR SYSTEM INJURIES;

ANIMALS; AORTA, THORACIC; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CELL MOVEMENT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; ENZYME INHIBITORS; FEMORAL ARTERY; INSULIN; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOINTIMA; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; RE-EPITHELIALIZATION; SIGNAL TRANSDUCTION; TIME FACTORS; VASCULAR SYSTEM INJURIES; VASODILATION; VASODILATOR AGENTS;

EID: 84983159787     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.04.799     Document Type: Article

References (50)

1. Muniyappa R., Montagnani M., Koh K.K., Quon M.J. Cardiovascular actions of insulin. Endocr. Rev. 2007, 28:463-491.
2. Napoli C., Ignarro L.J. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch. Pharm. Res. 2009, 32:1103-1108.
3. Moussa I., Leon M.B., Baim D.S., O'Neill W.W., Popma J.J., Buchbinder M., Midwall J., Simonton C.A., Keim E., Wang P., Kuntz R.E., Moses J.W. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004, 109:2273-2278.
4. Piatti P., Di Mario C., Monti L.D., Fragasso G., Sgura F., Caumo A., Setola E., Lucotti P., Galluccio E., Ronchi C., Origgi A., Zavaroni I., Margonato A., Colombo A. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003, 108:2074-2081.
5. Indolfi C., Torella D., Cavuto L., Davalli A.M., Coppola C., Esposito G., Carriero M.V., Rapacciuolo A., Di L.E., Stabile E., Perrino C., Chieffo A., Pardo F., Chiariello M. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats. Circulation 2001, 103:2980-2986.
6. Foster E., Zhang S., Kahn A.M. Insulin stimulates arterial neointima formation in normal rats after balloon injury. Diabetes Obes. Metab. 2006, 8:348-351.
7. Pu Q., Chang Y., Zhang C., Cai Y., Hassid A. Chronic insulin treatment suppresses PTP1B function, induces increased PDGF signaling, and amplifies neointima formation in the balloon-injured rat artery. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H132-H139.
8. Kubota T., Kubota N., Moroi M., Terauchi Y., Kobayashi T., Kamata K., Suzuki R., Tobe K., Namiki A., Aizawa S., Nagai R., Kadowaki T., Yamaguchi T. Lack of insulin receptor substrate-causes progressive neointima formation in response to vessel injury. Circulation 2003, 107:3073-3080.
9. Murthy S.N., Pankey E.A., Banka A.A., Badejo A.M., Wekerle R., Vilija V., Izadpanah R., Kadowitz P.J., Fonseca V.A. Effects of insulin detemir on balloon catheter injured carotid artery in Zucker fatty rats. J. Diabetes Complicat. 2012, 26:470-475.
10. Breen D.M., Chan K.K., Dhaliwall J.K., Ward M.R., Al Koudsi N., Lam L., De Souza M., Ghanim H., Dandona P., Stewart D.J., Bendeck M.P., Giacca A. Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1060-1066.
11. Breen D.M., Dhaliwall J.K., Chan K.K., Guo J., Lam L., Bendeck M.P., Giacca A. Insulin inhibits and oral sucrose increases neointimal growth after arterial injury in rats. J. Vasc. Res. 2010, 47:412-422.
12. 2+ but requires phosphorylation by Akt at Ser(1179). J. Biol. Chem. 2001, 276:30392-30398.
13. Di L.A., Lin M.I., Murata T., Landskroner-Eiger S., Schleicher M., Kothiya M., Iwakiri Y., Yu J., Huang P.L., Sessa W.C. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases. J. Cell. Sci. 2013, 126:5541-5552.
14. Ambrosini M.V., Mariucci G., Rambotti M.G., Tantucci M., Covarelli C., De A.L., Del S.P. Ultrastructural investigations on protective effects of NCX 4016 (nitroaspirin) on macrovascular endothelium in diabetic Wistar rats. J. Submicrosc. Cytol. Pathol. 2005, 37:205-213.
15. Li Q., Atochin D., Kashiwagi S., Earle J., Wang A., Mandeville E., Hayakawa K., d'Uscio L.V., Lo E.H., Katusic Z., Sessa W., Huang P.L. Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size. Stroke 2013, 44:3183-3188.
16. Wallace J.L., Del S.P., Cirino G., Muscara M.N. Nitric oxide-releasing NSAIDs: GI-safe antithrombotics. IDrugs 1999, 2:321-326.
17. Begum N., Ragolia L. High glucose and insulin inhibit VSMC MKP-expression by blocking iNOS via p38 MAPK activation. Am. J. Physiol. Cell. Physiol. 2000, 278:C81-C91.
18. Kahn A.M., Allen J.C., Seidel C.L., Lichtenberg D.S., Song T., Zhang S. Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E627-E633.
19. Kahn A.M., Allen J.C., Seidel C.L., Zhang S. Insulin inhibits migration of vascular smooth muscle cells with inducible nitric oxide synthase. Hypertension 2000, 35:303-306.
20. Breen D.M., Dolinsky V.W., Zhang H., Ghanim H., Guo J., Mroziewicz M., Tsiani E.L., Bendeck M.P., Dandona P., Dyck J.R., Heximer S.P., Giacca A. Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism. Atherosclerosis 2012, 222:375-381.
21. Clowes A.W., Reidy M.A., Clowes M.M. Mechanisms of stenosis after arterial injury. Lab. Invest 1983, 49:208-215.
22. Ramzy D., Wallen J., Badiwala M.V., Tumiati L.C., Tepperman E., Ross H.J., Delgado D.H., Rao V. Endothelin-antagonism and nitric oxide augmentation prevents cyclosporine-induced vasomotor impairment. J. Heart Lung Transpl. 2011, 30:77-85.
23. Bess E., Fisslthaler B., Fromel T., Fleming I. Nitric oxide-induced activation of the AMP-activated protein kinase alpha2 subunit attenuates IkappaB kinase activity and inflammatory responses in endothelial cells. PLoS One 2011, 6:e20848.
24. Butt E., Bernhardt M., Smolenski A., Kotsonis P., Frohlich L.G., Sickmann A., Meyer H.E., Lohmann S.M., Schmidt H.H. Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J. Biol. Chem. 2000, 275:5179-5187.
25. Li H., Wallerath T., Forstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric. Oxide 2002, 7:132-147.
26. Oelze M., Mollnau H., Hoffmann N., Warnholtz A., Bodenschatz M., Smolenski A., Walter U., Skatchkov M., Meinertz T., Munzel T. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ. Res. 2000, 87:999-1005.
27. Major T.C., Overhiser R.W., Panek R.L. Evidence for NO involvement in regulating vascular reactivity in balloon-injured rat carotid artery. Am. J. Physiol. 1995, 269:H988-H996.
28. Cho M.K., Suh S.H., Kim S.G. JunB/AP-and NF-kappa B-mediated induction of nitric oxide synthase by bovine type I collagen in serum-stimulated murine macrophages. Nitric. Oxide 2002, 6:319-332.
29. Guo J., Dhaliwall J.K., Chan K.K., Ghanim H., Al K.N., Lam L., Madadi G., Dandona P., Giacca A., Bendeck M.P. In vivo effect of insulin to decrease matrix metalloproteinase-and -activity after arterial injury. J. Vasc. Res. 2013, 50:279-288.
30. von der Thusen J.H., Fekkes M.L., Passier R., van Zonneveld A.J., Mainfroid V., van Berkel T.J., Biessen E.A. Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:357-362.
31. Moroi M., Zhang L., Yasuda T., Virmani R., Gold H.K., Fishman M.C., Huang P.L. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J. Clin. Invest 1998, 101:1225-1232.
32. Iwakura A., Luedemann C., Shastry S., Hanley A., Kearney M., Aikawa R., Isner J.M., Asahara T., Losordo D.W. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 2003, 108:3115-3121.
33. Randriamboavonjy V., Fleming I. Endothelial nitric oxide synthase (eNOS) in platelets: how is it regulated and what is it doing there?. Pharmacol. Rep. 2005, 57(Suppl):59-65.
34. Gonzalez-Fernandez F., Lopez-Farre A., Rodriguez-Feo J.A., Farre J., Guerra J., Fortes J., Millas I., Garcia-Duran M., Rico L., Mata P., de Miguel L.S., Casado S. Expression of inducible nitric oxide synthase after endothelial denudation of the rat carotid artery: role of platelets. Circ. Res. 1998, 83:1080-1087.
35. Chyu K.Y., Dimayuga P., Zhu J., Nilsson J., Kaul S., Shah P.K., Cercek B. Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ. Res. 1999, 85:1192-1198.
36. Cooney R., Hynes S.O., Sharif F., Howard L., O'Brien T. Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury. Gene Ther. 2007, 14:396-404.
37. Morishita T., Tsutsui M., Shimokawa H., Horiuchi M., Tanimoto A., Suda O., Tasaki H., Huang P.L., Sasaguri Y., Yanagihara N., Nakashima Y. Vasculoprotective roles of neuronal nitric oxide synthase. FASEB J. 2002, 16:1994-1996.
38. Yu W.J., Juang S.W., Chin W.T., Chi T.C., Chang C.J., Cheng J.T. Insulin restores neuronal nitric oxide synthase expression in streptozotocin-induced diabetic rats. Life Sci. 2000, 68:625-634.
39. Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W., Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9114-9119.
40. Sinnaeve P., Chiche J.D., Gillijns H., Van P.N., Wirthlin D., Van De W.F., Collen D., Bloch K.D., Janssens S. Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis. Circulation 2002, 105:2911-2916.
41. Tsai E.J., Kass D.A. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol. Ther. 2009, 122:216-238.
42. Sahara M., Sata M., Morita T., Nakajima T., Hirata Y., Nagai R. A phosphodiesterase-inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1315-1324.
43. Doppler H., Storz P. Regulation of VASP by phosphorylation: consequences for cell migration. Cell. Adh. Migr. 2013, 7:482-486.
44. Kuhn M., Volker K., Schwarz K., Carbajo-Lozoya J., Flogel U., Jacoby C., Stypmann J., van E.M., Gambaryan S., Hartmann M., Werner M., Wieland T., Schrader J., Baba H.A. The natriuretic peptide/guanylyl cyclase-system functions as a stress-responsive regulator of angiogenesis in mice. J. Clin. Invest 2009, 119:2019-2030.
45. Upmacis R.K., Deeb R.S., Resnick M.J., Lindenbaum R., Gamss C., Mittar D., Hajjar D.P. Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells. Am. J. Physiol. Cell. Physiol. 2004, 286:C1271-C1280.
46. Jacob A., Molkentin J.D., Smolenski A., Lohmann S.M., Begum N. Insulin inhibits PDGF-directed VSMC migration via NO/cGMP increase of MKP-and its inactivation of MAPKs. Am. J. Physiol. Cell. Physiol. 2002, 283:C704-C713.
47. Kim S.Y., Kwon Y.W., Jung I.L., Sung J.H., Park S.G. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCalpha-mediated MKP-induction. Cardiovasc. Res. 2011, 92:307-316.
48. Bandyopadhyay G., Standaert M.L., Zhao L., Yu B., Avignon A., Galloway L., Karnam P., Moscat J., Farese R.V. Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport. J. Biol. Chem. 1997, 272:2551-2558.
49. Selemidis S., Dusting G.J., Peshavariya H., Kemp-Harper B.K., Drummond G.R. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc. Res. 2007, 75:349-358.
50. Zhou N., Yu Q.J., Si R., Gao H.K., Wang T., Gao F., Wang H.C., Bian J.F. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia. J. Cardiovasc. Pharmacol. 2010, 56:402-412.